|
|
PD13-01 LOSS OF FOXA1 EXPRESSION IS ASSOCIATED WITH ADVERSE PATHOLOGIC FEATURES AND INFERIOR ONCOLOGIC OUTCOMES FOLLOWING RADICAL NEPHROURETERECTOMY
Lauren Shuman
,
Joshua Warrick
,
David Degraff
,
Shahrokh Shariat
,
Jose Karam
et al.
Journal of Urology, 2016, 2016 Annual Meeting Program Abstracts AUA Annual Meeting, 195 (4, Supplement), pp.e298. ⟨10.1016/j.juro.2016.02.972⟩
Journal articles
hal-01300790v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of Tumor Location on Prognosis for Patients with Upper Tract Urothelial Carcinoma Managed by Radical Nephroureterectomy.
Jay D. Raman
,
Casey K. Ng
,
Douglas S. Scherr
,
Vitaly Margulis
,
Yair Lotan
et al.
Journal articles
istex
inserm-00410859v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Phase 2 Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Hagop M. Kantarjian
,
Bruno Lioure
,
Ehab Atallah
,
Thibaut Leguay
,
Kevin Kelly
et al.
Journal articles
hal-01259441v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract
Jay D. Raman
,
Joshua I. Warrick
,
Carla Caruso
,
Zhaohai Yang
,
Lauren Shuman
et al.
Journal articles
hal-01435010v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|